July 14, 2008
Ukraine Pharmaceuticals and Healthcare Report Q2 2008 Provides Competitive Intelligence on Ukraine’s Pharmaceuticals and Healthcare Industry
Research and Markets (http://www.researchandmarkets.com/research/286bf5/ukraine_pharmaceut) has announced the addition of the "Ukraine Pharmaceuticals and Healthcare Report Q2 2008" report to their offering.
The Ukraine Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Ukraine's pharmaceuticals and healthcare industry.BMI forecasts that Ukraine's pharmaceutical market will grow by 12% in 2008, following 22% growth recorded in 2007. Our updated five-year forecast for the period 2007 to 2012 envisions an annual average growth rate of 8.7% reaching a total value of US$3.65bn, reflecting slowing growth towards the end of the forecast period. Much depends on the Ukrainian government's ability to deliver on promises to introduce major healthcare reform and a level of universal coverage. If successful, the market could see strong double-digit rates through the forecast period. But BMI remains deeply sceptical about the central government's ability to deliver reform.
From a regulatory perspective, Ukraine's accession to the World Trade Organisation (WTO) -- agreed and due to be completed later this year -- is a major boost for long-term improvements in the intellectual property (IP) environment and more immediately, an elimination of duties on pharmaceuticals for member countries. This should provide the biggest boost for generics makers in Central and Eastern Europe (CEE). While accession is a clear plus for patented drug makers, poor enforcement of IP laws and a lack of government and private-sector buying power will remain major barriers for some years to come.
Key Topics Covered: Executive Summary Ukraine Pharmaceutical And Healthcare Industry SWOT Ukraine Political SWOT Ukraine Economic SWOT Ukraine Business Environment SWOT Pharmaceutical Business Environment Ratings Pharmaceutical Ratings - Revised Methodology Ratings Overview Table: Pharmaceutical Business Environment Indicators Weighting Table: Weighting Of Components Ukraine - Pharmaceutical Business Environment Rating Table: Central And Eastern Europe Pharmaceutical Business Environment Rankings Limits To Potential Returns Risk To Realisation Of Returns Ukraine - Market Summary Regulatory Regime Intellectual Property Issues Pricing And Reimbursement Issues Other Market Entry Barriers Industry Developments Industry Forecast Scenario Overall Market Forecast Table: Ukraine's Drug Market Indicators Key Growth Factors - Industry Table: Health Expenditure Indicators Key Growth Factors - Macroeconomic Economic Activity Ukraine - Economic Activity OTC Market Forecast Table: OTC Market Indicators (US$mn unless otherwise stated) Prescription Market Forecast Table: Prescription Drug Market Indicators (US$mn unless otherwise stated) Generics Market Forecast Table: Generic And Patented Drugs Market Indicators Export/Import Forecasts Table: Import/Export Forecasts (US$mn) Other Healthcare Data Forecasts Table: Healthcare Data Competitive Landscape Manufacturing Sector Wholesale Retail Table: Pharmacies And Pharmacy Market Ratios Company Monitors - Arterium - Gedeon Richter - Krka - Lek (Novartis/Sandoz) BMI Forecast Modelling How We Generate Our Industry Forecasts Pharmaceutical Industry Sources Companies Mentioned: - Arterium - Gedeon Richter - Krka - Lek (Novartis/Sandoz)
For more information visit http://www.researchandmarkets.com/research/286bf5/ukraine_pharmaceut